The model improves anti-TNF drug selection and the effect of genetic markers across multiple cohorts.
This is the first study to examine the real-world outcome of the management of RA using neutrophil-lymphocyte ratio.
The study identified biomarkers for changes in bone mineral density at three anatomic sites in patients with osteoporosis secondary to RA.
We examine rheumatoid arthritis and jaw pain: prevalence, symptoms, and tips for your patients to manage their pain.
The FDA has approved changes to the prescribing information for tofacitinib to include new warnings, including a Boxed Warning, regarding an increased risk of blood clots and death.